UH
BIIB icon

Unigestion Holding’s Biogen BIIB Stock Holding History

Unigestion Holding’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,383
Closed -$392K – 228
2020
Q3 		$392K Sell
1,383
-198
-13% -$55.2K 0.01% 166
2020
Q2 		$423K Sell
1,581
-1,112
-41% -$334K 0.01% 170
2020
Q1 		$852K Buy
+2,693
New +$817K 0.03% 171
2019
Q3 		$1.28M Buy
5,479
+1,519
+38% +$354K 0.04% 159
2019
Q2 		$926K Buy
3,960
+1,564
+65% +$361K 0.02% 192
2019
Q1 		$566K Buy
2,396
+780
+48% +$246K 0.02% 218
2018
Q4 		$486K Sell
1,616
-731
-31% -$233K 0.01% 270
2018
Q3 		$829K Sell
2,347
-623
-21% -$214K 0.02% 271
2018
Q2 		$862K Buy
+2,970
New +$835K 0.02% 271

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Unigestion Holding's BIIB Position: Q4 2020 in Review

Unigestion Holding sold out of Biogen (BIIB) in Q4 2020, closing a stake of 1,383 shares — an estimated $392K sold.

Unigestion Holding first reported a position in BIIB in Q2 2018 and held it in 9 quarters. The position peaked at $1.28M in Q3 2019. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Unigestion Holding reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Unigestion Holding sold 1,383 Biogen shares in Q4 2020, an estimated $392K.
  • Unigestion Holding first reported a position in Biogen in Q2 2018 and held it in 9 quarters.
  • Unigestion Holding's Biogen position peaked at $1.28M in Q3 2019.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Unigestion Holding's 13F filing for Q4 2020, filed 16 Feb 2021.